Study on Hypoglycemic and Hypolipidemic Compounds in Sanhuang Decoction by Multi-target Affinity Ultrafiltration LC-MS

被引:0
作者
Xu, Yong-Bing [1 ,2 ,3 ]
Guo, Ming-Quan [1 ,2 ,3 ]
机构
[1] Laboratory of Аdvanced Theranostic Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Аcademy of Sciences, Ningbo
[2] Ningbo Cixi Institute of Biomedical Engineering, Ningbo
[3] Key Laboratory of Plant Germplasm Enhancement and Specialty Аgriculture, Wuhan Botanical Garden, Chinese Аcademy of Sciences, Wuhan
关键词
affinity ultrafiltration mass spectrometry; hypoglycemic activity; hypolipidemic activity; molecular docking; Sanhuang decoction;
D O I
10.7538/zpxb.2024.0099
中图分类号
学科分类号
摘要
Sanhuang decoction, a traditional Chinese medicine prescription, was firstly described in Golden Chamber by Zhang Zhongjing in the Han Dynasty, and has been used clinically for thousands of years to treat diabetes and obesity. However, the specific bioactive compounds being responsible for the hypoglycemic and hypolipidemic effects of Sanhuang decoction and the underlying therapeutic mechanism remain elusive, and further research efforts are in great need. Hence, the aim of this study was to discover the potential hypoglycemic and hypolipidemic phytochemicals in Sanhuang decoction and to explore their potential mechanisms of action. Here, the in vitro α-glucosidase (α-Glu) and lipase (LP) inhibitory activities of Sanshuang decoction were determined, and the results showed that Sanhuang decoction possesses significant α-Glu and LP inhibitory activities in vitro. Then, 24, 17 and 25 potential bioactive ligands in Sanhuang decoction are successfully captured by combining affinity ultrafiltration liquid chromatography-mass spectrometry with three drug targets, namely α-Glu, α-amylase (α-Amy) and LP, respectively. These potential bioactive ingredients fished out from Sanhuang decoction exhibit various binding capacities to α-Glu, α-Amy and LP, respectively. Thereof, epicatechin-3-О-gallate possesses significant hypoglycemic and hypolipidemic effects. Finally, some representative active ligands were further verified with molecular docking assay, and the molecular docking results are consistent with those of affinity ultrafiltration. Furthermore, in addition to hydrogen bond (H-bond), there are various other interaction forces between these potential bioactive ingredients and their corresponding target enzymes, such as Pi-Sigma, Pi-Pi T-shaped and Pi-Alkyl interactions. In this study, the potential hypoglycemic and hypolipidemic constituents in Sanshuang decoction were explored and identified by using affinity ultrafiltration liquid chromatography-mass spectrometry with three drug targets tightly correlating to the metabolisms of blood sugar and lipids in the human body, and the effective material basis of Sanshuang decoction can thus be preliminarily clarified. In this way, the interaction network among these bioactive compounds and three drug targets were constructed, thus providing theoretical support for the clinical applications of Sanhuang decoction for the treatments of obesity and diabetes. © 2024 Chinese Society for Mass Spectrometry. All rights reserved.
引用
收藏
页码:810 / 822
页数:12
相关论文
共 29 条
  • [1] BRADLEY C, ESCHWEGE E, de PABLOS-VELASCO P, PARHOFER K G, SIMON D, VANDENBERGHE H, GONDER-FREDERICK L., Predictors of quality of life and other patient-reported outcomes in the PANORAMA multinational study of people with type 2 diabetes, Diabetes Care, 41, 2, pp. 267-276, (2018)
  • [2] LI S, ZHANG W, WANG R, LI C, LIN X, WANG L., Screening and identification of natural α-glucosidase and α-amylase inhibitors from partridge tea (Mallotus furetianus Muell-Arg) and in silico analysis, Food Chemistry, 388, (2022)
  • [3] GAUR P, KHAN F, SHANKER K., Potential lipase inhibitor from underutilized part of Аndrographis paniculata: targeted isolation and mechanism of inhibition, Industrial Crops and Products, 197, pp. 116-623, (2023)
  • [4] OBOH G, OGUNSUYI O B, OGUNBADEJO M D, ADEFEGHA S A., Influence of Gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose, Journal of Food and Drug Analysis, 24, 3, pp. 627-634, (2016)
  • [5] XIE L, XIE J, XU Y, CHEN W., Discovery of anthocyanins from cranberry extract as pancreatic lipase inhibitors using a combined approach of ultrafiltration, molecular simulation and spectroscopy, Food & Function, 11, 10, pp. 8527-8536, (2020)
  • [6] SUN S, WANG W, WANG N, ZHANG Y, ZHU Z, LI X, WANG J, CHEN Q, SADIQ F, YANG H, QI Q, ZHANG G., HPP and SGQR peptides from silkworm pupae protein hydrolysates regulated biosynthesis of cholesterol in HepG2 cell line, Journal of Functional Foods, 77, pp. 104-328, (2021)
  • [7] CHEN Zhejie, LI Wen, LIN Meisi, HE Yao, FU Chaomei, GAO Fei, ZHANG Jinming, Research status of Sanhuang Xiexin Decoction and analyses of key technologies and core issues, Chinese Traditional and Herbal Drugs, 47, 22, pp. 4111-4117, (2016)
  • [8] FANG P, SUN Y, GU X, HAN L, HAN S, SHANG Y, LUAN Z, LU N, GE R, SHI M, ZHANG Z, MIN W., San-Huang-Tang protects obesity/diabetes induced NAFLD by upregulating PGC-1α/PEPCK signaling in obese and galr1 knockout mice models, Journal of Ethnopharmacology, 250, pp. 112-483, (2020)
  • [9] XIAO S, ZHANG Z, CHEN M, ZOU J, JIANG S, QIAN D, DUAN J., Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut micro-biota-derived short chain fatty acids production and adjusting energy metabolism, Journal of Ethnopharmacology, 241, (2019)
  • [10] CHEN D, CHEN X, HE C, XIAO C, CHEN Z, CHEN Q, CHEN J, BO H., Sanhuang Xiexin Decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM, Journal of Ethnopharmacology, 306, pp. 116-162, (2023)